Cost-effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.

JM Gaspoz, PG Coxson, PA Goldman, LW Williams, KM Kuntz, Myriam Hunink, L Goldman

Research output: Contribution to journalArticleAcademicpeer-review

258 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1800-1806
Number of pages7
JournalNew England Journal of Medicine
Volume346
DOIs
Publication statusPublished - 2002

Research programs

  • EMC NIHES-01-64-03
  • EMC NIHES-03-30-02

Cite this